Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Detection of Celiac Disease in Patients With Hypothyroidism

This study has been completed.
Information provided by (Responsible Party):
Richard Zubarik, University of Vermont Identifier:
First received: May 20, 2013
Last updated: December 5, 2014
Last verified: December 2014
The study evaluates whether hypothyroid patients requiring elevated doses of levothyroxine to maintain a euthyroid state are at increased risk of having celiac disease. It also attempts to determine if there is a threshold level of levothyroxine needed to maintain a euthyroid state in patients with hypothyroidism that should prompt serologic testing for celiac disease.

Celiac Disease
Celiac Sprue

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Detection of Celiac Disease in Patients With Hypothyroidism

Resource links provided by NLM:

Further study details as provided by University of Vermont:

Primary Outcome Measures:
  • presence of celiac disease [ Time Frame: 1 month ]

Secondary Outcome Measures:
  • Symptoms associated with celiac disease [ Time Frame: 6 months ]
    a short questionnaire will be filled out at the time of serologic testing. If a patient hads celiac disease the form will be filled out again at 6 months after diagnosis.

  • medication adjustment [ Time Frame: 6 months ]
    Patients diagnosed with celiac disease who initiate a gluten free diet will be assessed to determine whether adjustment of levothyroxine dosing is necessary

Enrollment: 500
Study Start Date: March 2012
Study Completion Date: December 2014
Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Detailed Description:
This study is looking at whether hypothyroid patients who require above 125 mcg/day (or >1.5mcg/kg/day) of levothyroxine are more likely to have celiac disease than those who require smaller doses. It also looks to see if the prevalence of celiac disease in hypothyroid patients who require elevated doses of levothyroxine is high enough to warrant screening in that population.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Patients with hypothyroidism who take thyroid replacement therapy

Inclusion Criteria:

  • Patients with the diagnosis of hypothyroidism that require thyroid replacement therapy.

Exclusion Criteria:

  • Surgical resection of thyroid tissue, neck irradiation, radioactive iodine therapy, prior medical treatment with lithium, methimazole, propylthiouracil, ethionamide, amiodarone, or sunitinib, prior serologic testing for celiac disease.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01862510

United States, Vermont
Fletcher Allen Health Care
Burlington, Vermont, United States, 05405
Sponsors and Collaborators
University of Vermont
Principal Investigator: Richard Zubarik, MD University of Vermont
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Richard Zubarik, MD, University of Vermont Identifier: NCT01862510     History of Changes
Other Study ID Numbers: ZUBM12133
Study First Received: May 20, 2013
Last Updated: December 5, 2014

Keywords provided by University of Vermont:
Celiac Disease
Celiac Sprue

Additional relevant MeSH terms:
Celiac Disease
Malabsorption Syndromes
Intestinal Diseases
Gastrointestinal Diseases
Digestive System Diseases
Metabolic Diseases
Thyroid Diseases
Endocrine System Diseases processed this record on May 22, 2017